Profil
Curtis Rambaran is currently Chief Medical Officer at Silence Therapeutics Plc since 2023.
Dr. Rambaran was Head-European Translational Medicine at Daiichi Sankyo UK Ltd. from 2016 to 2023.
Dr. Rambaran earned a doctorate from The University of the West Indies.
Postes actifs de Curtis Rambaran
| Sociétés | Poste | Début |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Anciens postes connus de Curtis Rambaran
| Sociétés | Poste | Fin |
|---|---|---|
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 01/12/2023 |
Formation de Curtis Rambaran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The University of the West Indies
The University of the West Indies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
















